The popularity of the drugs has surged, with an estimated 1 in 8 Americans saying they are taking them, according to a KFF poll
Some people reach a plateau where weight loss slows or stops temporarily
Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinsons disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: the Exenatide-PD3 study
The strongest counter-positions are these
A rare potential risk that adds a few extra cases per 10,000 over 18 months is something doctors will note, screen for, and discuss
Then you can go back to your regular weekly schedule